Part of

Tools

CancerTools offers a wide range of cancer research tools including antibodies, cell lines, PDX models, mouse models, proteins, small molecules and vectors across a range of cancer areas. Explore our collection.

Showing 1051–1075 of 3958 results

Cat. #

Tool Name

Tool Category

161187

MCF10A-EGFR1m-20 cell line

Cell lines

Key Info

Cat. #:	161187
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Epidermal growth factor receptor [EGFR]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161188

MCF10A-EGFR1m-21 cell line

Cell lines

Key Info

Cat. #:	161188
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Epidermal growth factor receptor [EGFR]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161189

MCF10A-ERRB2m-Control cell line

Cell lines

Key Info

Cat. #:	161189
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Erb-b2 receptor tyrosine kinase 2 [ERBB2]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161190

MCF10A-ERRB2m-1 cell line

Cell lines

Key Info

Cat. #:	161190
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Erb-b2 receptor tyrosine kinase 2 [ERBB2]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161191

MCF10A-ERRB2m-2 cell line

Cell lines

Key Info

Cat. #:	161191
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Erb-b2 receptor tyrosine kinase 2 [ERBB2]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161192

MCF10A-ERRB2m-3 cell line

Cell lines

Key Info

Cat. #:	161192
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Erb-b2 receptor tyrosine kinase 2 [ERBB2]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161193

MCF10A-ERRB2m-4 cell line

Cell lines

Key Info

Cat. #:	161193
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Erb-b2 receptor tyrosine kinase 2 [ERBB2]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161194

MCF10A-ERRB2m-5 cell line

Cell lines

Key Info

Cat. #:	161194
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Erb-b2 receptor tyrosine kinase 2 [ERBB2]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161195

MCF10A-ERRB2m-6 cell line

Cell lines

Key Info

Cat. #:	161195
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Erb-b2 receptor tyrosine kinase 2 [ERBB2]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161196

MCF10A-ERRB2m-7 cell line

Cell lines

Key Info

Cat. #:	161196
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Erb-b2 receptor tyrosine kinase 2 [ERBB2]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161197

MCF10A-ERRB2m-8 cell line

Cell lines

Key Info

Cat. #:	161197
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Erb-b2 receptor tyrosine kinase 2 [ERBB2]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161198

MCF10A-ERRB2m-9 cell line

Cell lines

Key Info

Cat. #:	161198
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Erb-b2 receptor tyrosine kinase 2 [ERBB2]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161199

MCF10A-ERRB2m-10 cell line

Cell lines

Key Info

Cat. #:	161199
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Erb-b2 receptor tyrosine kinase 2 [ERBB2]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161200

MCF10A-ERRB2m-11 cell line

Cell lines

Key Info

Cat. #:	161200
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Erb-b2 receptor tyrosine kinase 2 [ERBB2]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161201

MCF10A-ERRB2m-12 cell line

Cell lines

Key Info

Cat. #:	161201
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Erb-b2 receptor tyrosine kinase 2 [ERBB2]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161202

MCF10A-ERRB2m-13 cell line

Cell lines

Key Info

Cat. #:	161202
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Erb-b2 receptor tyrosine kinase 2 [ERBB2]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161203

MCF10A-PTENm-Control cell line

Cell lines

Key Info

Cat. #:	161203
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Phosphatase and tensin homolog [PTEN]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161204

MCF10A-PTENm-1 cell line

Cell lines

Key Info

Cat. #:	161204
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Phosphatase and tensin homolog [PTEN]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161205

MCF10A-PTENm-2 cell line

Cell lines

Key Info

Cat. #:	161205
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Phosphatase and tensin homolog [PTEN]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161206

MCF10A-PTENm-3 cell line

Cell lines

Key Info

Cat. #:	161206
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Phosphatase and tensin homolog [PTEN]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161207

MCF10A-PTENm-4 cell line

Cell lines

Key Info

Cat. #:	161207
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Phosphatase and tensin homolog [PTEN]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161208

MCF10A-PTENm-5 cell line

Cell lines

Key Info

Cat. #:	161208
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	Phosphatase and tensin homolog [PTEN]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161209

MCF10A-AKTm-Control cell line

Cell lines

Key Info

Cat. #:	161209
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	AKT serine/threonine kinase 1 [AKT1]
Application:	Functional analysis of mutated genes, Drug screening

View Tool

161210

MCF10A-AKTm-1 cell line

Cell lines

Key Info

Cat. #:	161210
Sub-type:	Continuous
Availability:	8-10 weeks
Target:	AKT serine/threonine kinase 1 [AKT1]
Application:	Functional analysis of mutated genes, Drug screening